AMN HEALTHCARE ANNOUNCES SECOND QUARTER 2026 RESULTS
AMN Healthcare Services (NYSE: AMN) reported Q2 2026 revenue of $673 million, up 2% year over year, and adjusted EBITDA of $73 million. GAAP net income was $21 million, or $0.53/share, and adjusted EPS was $0.77. The company said results exceeded guidance, citing travel nurse and allied growth, 27% search revenue growth, and acquisitions expanding AI and leadership offerings. Q3 revenue is expected 1-3% higher.
How this was made
The 30-second read
Why it matters
Q2 results beat guidance with higher adjusted EPS and EBITDA margin, and management guided Q3 revenue up 1-3% YoY while segment trends diverge (Nurse and Allied up, Physician and Leadership down, Technology down). Cash flow from operations was negative in Q2 due to client deposit returns tied to prior labor disruption events.
Market read
Traders can update valuation and positioning based on the reported beat, margin/EBITDA improvement, and the explicit Q3 revenue and segment outlook ranges.
What to watch
Technology and Workforce Solutions revenue is down year over year, and Physician and Leadership Solutions is also down, which could cap upside if the staffing recovery does not broaden.
Background
AMN Healthcare Services is a healthcare staffing and workforce solutions provider, with segments spanning Nurse and Allied, Physician and Leadership, and Technology and Workforce.
Ticker impact
AMN reported Q2 2026 revenue of $673M, adjusted EPS of $0.77, and beat guidance, citing travel nurse and search strength plus labor-disruption effects.
Near-term bias positive on earnings quality and guidance momentum, but expect volatility around cash flow and segment mix.
The article provides concrete Q2 financials, margin/EBITDA improvement, and explicit Q3 revenue and segment outlook ranges, which are actionable for positioning. However, it also highlights sequential cash flow weakness and deposit settlement timing, which can temper the reaction.
Market effects
Healthcare staffing and workforce solutions demand appears to be stabilizing, with search and language services showing relative strength/weakness by segment.
Primarily US healthcare labor markets, with international nurse and executive/physician placement contributing to mix.
Limited direct global read-through; language services and AI-native access could matter for broader healthcare services demand.
Counterpoint
The sequential revenue decline and negative operating cash flow suggest the earnings quality may be supported by timing effects (reserve releases, billing true-ups) and deposit movements rather than durable cash generation.
Key entities
- companyAMN Healthcare Services, Inc.
Reported Q2 2026 financial results and provided Q3 2026 outlook, including segment-level revenue expectations.
- acquisitionJaide Health
Recent acquisition expanding AMN’s AI-native language access solutions.
- acquisitionESSENTIAL Leadership Assessment
Recent acquisition expanding AMN’s leadership advisory capabilities.
- executiveCary Grace
CEO who commented on demand improvement through the quarter and momentum into Q3 guidance.
